{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:40:27Z","timestamp":1792716027127,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272392"],"award-info":[{"award-number":["82272392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05407-8","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:00:30Z","timestamp":1785225630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in antimicrobial resistance of clinical isolates of Proteus, Morganella, and Providencia species from regional hospitals in Zhejiang Province, 2020\u2009~\u20092024"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhengliang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"5407_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1128\/cmr.13.4.534","volume":"13","author":"CM O\u2019Hara","year":"2000","unstructured":"O\u2019Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13:534\u201346. https:\/\/doi.org\/10.1128\/cmr.13.4.534.","journal-title":"Clin Microbiol Rev"},{"key":"5407_CR2","doi-asserted-by":"publisher","unstructured":"Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis Infection. EcoSal Plus. 2018;8. https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0009-2017.","DOI":"10.1128\/ecosalplus.ESP-0009-2017"},{"key":"5407_CR3","doi-asserted-by":"publisher","unstructured":"Schaffer JN, Pearson MM. Proteus mirabilis and Urinary Tract Infections. Microbiol Spectr. 2015;3. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0017-2013.","DOI":"10.1128\/microbiolspec.UTI-0017-2013"},{"key":"5407_CR4","unstructured":"CHINET surveillance of antimicrobial resistance among the bacterial isolates in 2021. Chinese Journal of Infection and Chemotherapy. 2022;22(5):521\u2013530."},{"key":"5407_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","volume":"41","author":"S Yaghoubi","year":"2022","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, Ghafouri Z, Maleki F. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41:1003\u201322. https:\/\/doi.org\/10.1007\/s10096-020-04121-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5407_CR6","doi-asserted-by":"publisher","first-page":"e47494","DOI":"10.7759\/cureus.47494","volume":"15","author":"RA El-Kady","year":"2023","unstructured":"El-Kady RA, Alotaibi SA, Aljabri TT, Haraka RR, Ibrahim IM, Mousa AI, Bashbeshi MW. Antimicrobial Susceptibility Trends of Proteeae Isolates From a Tertiary-Care Hospital in Western Saudi Arabia. Cureus. 2023;15:e47494. https:\/\/doi.org\/10.7759\/cureus.47494.","journal-title":"Cureus"},{"key":"5407_CR7","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/s2666-5247(23)00407-x","volume":"5","author":"RA Bonnin","year":"2024","unstructured":"Bonnin RA, Creton E, Perrin A, Girlich D, Emeraud C, Jousset AB, Duque M, Jacquemin A, Hopkins K, Bogaerts P, et al. Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study. Lancet Microbe. 2024;5:e547\u201358. https:\/\/doi.org\/10.1016\/s2666-5247(23)00407-x.","journal-title":"Lancet Microbe"},{"key":"5407_CR8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","volume":"69","author":"PD Tamma","year":"2019","unstructured":"Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ. A Primer on AmpC \u03b2-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World. Clin Infect Dis. 2019;69:1446\u201355. https:\/\/doi.org\/10.1093\/cid\/ciz173.","journal-title":"Clin Infect Dis"},{"key":"5407_CR9","doi-asserted-by":"publisher","first-page":"dlae150","DOI":"10.1093\/jacamr\/dlae150","volume":"6","author":"MG Wise","year":"2024","unstructured":"Wise MG, DeRyke CA, Alekseeva I, Siddiqui F, Young K, Motyl MR, Sahm DF. Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane\/tazobactam, imipenem\/relebactam and comparators: SMART 2018-22. JAC Antimicrob Resist. 2024;6:dlae150. https:\/\/doi.org\/10.1093\/jacamr\/dlae150.","journal-title":"JAC Antimicrob Resist"},{"key":"5407_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/cmr.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440\u201358. https:\/\/doi.org\/10.1128\/cmr.00001-07. table of contents.","journal-title":"Clin Microbiol Rev"},{"key":"5407_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jac\/dkh047","volume":"53","author":"M Tumbarello","year":"2004","unstructured":"Tumbarello M, Citton R, Spanu T, Sanguinetti M, Romano L, Fadda G, Cauda R. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother. 2004;53:277\u201382. https:\/\/doi.org\/10.1093\/jac\/dkh047.","journal-title":"J Antimicrob Chemother"},{"key":"5407_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.diagmicrobio.2014.09.021","volume":"81","author":"S Mahrouki","year":"2015","unstructured":"Mahrouki S, Chihi H, Bourouis A, Ayari K, Ferjani M, Moussa MB, Belhadj O. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6\u2019)-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn Microbiol Infect Dis. 2015;81:50\u20132. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.09.021.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5407_CR13","doi-asserted-by":"publisher","unstructured":"Witteveen S, Hans JB, Izdebski R, Hasman H, Samuelsen \u00d8, Dortet L, Pfeifer Y, Delappe N, Oteo-Iglesias J, \u017babicka D, et al. Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Euro Surveill. 2024;29. https:\/\/doi.org\/10.2807\/1560-7917.Es.2024.29.23.2300616.","DOI":"10.2807\/1560-7917.Es.2024.29.23.2300616"},{"key":"5407_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2015.09.013","volume":"84","author":"CAM Aires","year":"2016","unstructured":"Aires CAM, Almeida ACS, Vilela MA, Morais-Junior MA, Morais MMC. Selection of KPC-2-producing Providencia stuartii during treatment for septicemia. Diagn Microbiol Infect Dis. 2016;84:95\u20136. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.09.013.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5407_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijantimicag.2014.12.030","volume":"45","author":"E Douka","year":"2015","unstructured":"Douka E, Perivolioti E, Kraniotaki E, Fountoulis K, Economidou F, Tsakris A, Skoutelis A, Routsi C. Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit. Int J Antimicrob Agents. 2015;45:533\u20136. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.030.","journal-title":"Int J Antimicrob Agents"},{"key":"5407_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5578\/mb.67153","volume":"52","author":"B Otlu","year":"2018","unstructured":"Otlu B, Yakupo\u011fullar\u0131 Y, G\u00fcrsoy NC, Duman Y, Bay\u0131nd\u0131r Y, Tekereko\u011flu MS, Ersoy Y. [Co-production of OXA-48 and NDM-1 Carbapenemases in Providencia rettgeri: the first report]. Mikrobiyol Bul. 2018;52:300\u20137. https:\/\/doi.org\/10.5578\/mb.67153.","journal-title":"Mikrobiyol Bul"},{"key":"5407_CR17","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.2147\/idr.S418131","volume":"16","author":"Y Li","year":"2023","unstructured":"Li Y, Shao K, Cai R, Liu Y, Liu X, Ni F, Zheng H, Hu R, Sun T. Detection of NDM-1 and OXA-10 Co-Producing Providencia rettgeri Clinical Isolate. Infect Drug Resist. 2023;16:5319\u201328. https:\/\/doi.org\/10.2147\/idr.S418131.","journal-title":"Infect Drug Resist"},{"key":"5407_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nmni.2018.05.009","volume":"25","author":"M Abdallah","year":"2018","unstructured":"Abdallah M, Balshi A. First literature review of carbapenem-resistant Providencia. New Microbes New Infect. 2018;25:16\u201323. https:\/\/doi.org\/10.1016\/j.nmni.2018.05.009.","journal-title":"New Microbes New Infect"},{"key":"5407_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s44280-025-00092-0","volume":"3","author":"Y Guo","year":"2025","unstructured":"Guo Y, Ding L, Han R, Yin D, Wu S, Yang Y, Wang F, Zhu D, Hu F. the China Antimicrobial Surveillance Network Study, G. Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report. One Health Adv. 2025;3:23. https:\/\/doi.org\/10.1186\/s44280-025-00092-0.","journal-title":"One Health Adv"},{"key":"5407_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2334-13-19","volume":"13","author":"I Linhares","year":"2013","unstructured":"Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000\u20132009). BMC Infect Dis. 2013;13:19. https:\/\/doi.org\/10.1186\/1471-2334-13-19.","journal-title":"BMC Infect Dis"},{"key":"5407_CR21","doi-asserted-by":"publisher","unstructured":"Hrbacek J, Cermak P, Zachoval R. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011\u20132019. Antibiot (Basel). 2020;9. https:\/\/doi.org\/10.3390\/antibiotics9090630.","DOI":"10.3390\/antibiotics9090630"},{"key":"5407_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijantimicag.2016.01.008","volume":"47","author":"SS Jean","year":"2016","unstructured":"Jean SS, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, Kim MJ, Rajasekaram DG, Mendoza M, Tan TY, et al. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010\u20132013. Int J Antimicrob Agents. 2016;47:328\u201334. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.01.008.","journal-title":"Int J Antimicrob Agents"},{"key":"5407_CR23","doi-asserted-by":"publisher","unstructured":"Malviya M, Kale-Pradhan P, Coyle M, Giuliano C, Johnson LB. Clinical and Drug Resistance Characteristics of Providencia Infections. Microorganisms. 2024;12. https:\/\/doi.org\/10.3390\/microorganisms12102085.","DOI":"10.3390\/microorganisms12102085"},{"key":"5407_CR24","doi-asserted-by":"publisher","unstructured":"Zhu W, Liu Q, Liu J, Wang Y, Shen H, Wei M, Pu J, Gu L, Yang J. Genomic epidemiology and antimicrobial resistance of Morganella clinical isolates between 2016 and 2023. Front Cell Infect Microbiol. 2025;14\u20132024. https:\/\/doi.org\/10.3389\/fcimb.2024.1464736.","DOI":"10.3389\/fcimb.2024.1464736"},{"key":"5407_CR25","doi-asserted-by":"publisher","unstructured":"Gajd\u00e1cs M, Urb\u00e1n E. Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study. Antibiot (Basel). 2019;8. https:\/\/doi.org\/10.3390\/antibiotics8030091.","DOI":"10.3390\/antibiotics8030091"},{"key":"5407_CR26","doi-asserted-by":"publisher","first-page":"789646","DOI":"10.3389\/fcimb.2021.789646","volume":"11","author":"S Shen","year":"2021","unstructured":"Shen S, Huang X, Shi Q, Guo Y, Yang Y, Yin D, Zhou X, Ding L, Han R, Yu H, et al. Occurrence of NDM-1, VIM-1, and OXA-10 Co-Producing Providencia rettgeri Clinical Isolate in China. Front Cell Infect Microbiol. 2021;11:789646. https:\/\/doi.org\/10.3389\/fcimb.2021.789646.","journal-title":"Front Cell Infect Microbiol"},{"key":"5407_CR27","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/jac\/dkab111","volume":"76","author":"AI Moser","year":"2021","unstructured":"Moser AI, Viaggi V, Mauri C, Carattoli A, Luzzaro F, Endimiani A. An XDR Proteus vulgaris isolate hosting a novel blaNDM-1- and armA-carrying plasmid. J Antimicrob Chemother. 2021;76:1938\u201341. https:\/\/doi.org\/10.1093\/jac\/dkab111.","journal-title":"J Antimicrob Chemother"},{"key":"5407_CR28","unstructured":"(U.S.), C.f.D.C.a.P. Antimicrobial Resistance Threats in the United States, 2021\u20132022 Atlanta, GA, 2024."},{"key":"5407_CR29","unstructured":"Dall C. Global, US Data Show High Antibiotic Use, Rise in Resistant Infections During COVID. CIDRAP Center for Infectious Disease Research and Policy. 2024."},{"key":"5407_CR30","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/s1473-3099(18)30554-1","volume":"18","author":"S Portsmouth","year":"2018","unstructured":"Portsmouth S, van Veenhuyzen D, Echols R, Machida M, Ferreira JCA, Ariyasu M, Tenke P, Nagata TD. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2018;18:1319\u201328. https:\/\/doi.org\/10.1016\/s1473-3099(18)30554-1.","journal-title":"Lancet Infect Dis"},{"key":"5407_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","author":"PD Tamma","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae403.","journal-title":"Clin Infect Dis"},{"key":"5407_CR32","doi-asserted-by":"publisher","unstructured":"Posteraro B, De Maio F, Spanu T, Vidal Pereira MA, Fasano FR, Sanguinetti M. Characterization of Metallo \u03b2-Lactamase Producing Enterobacterales Isolates with Susceptibility to the Aztreonam\/Avibactam Combination. Antibiotics. 2024;13. https:\/\/doi.org\/10.3390\/antibiotics13121221.","DOI":"10.3390\/antibiotics13121221"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05407-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05407-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05407-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:29:46Z","timestamp":1792715386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05407-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5407"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05407-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of The Second Affiliated Hospital Zhejiang University School of Medicine (2025\u2009\u2212\u20090555). Informed consent to participate was obtained from all of the participants in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"917"}}